Article

Comprehensive Analysis of the Immune Microenvironment Reveals that CD52 is a Marker for Breast Cancer Treatment with Immune Checkpoint Inhibitors

2021-11-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold>Breast cancer (BC) is one of the most common tumors in women. Recent years, immune checkpoint inhibitors (ICIs) have brought good news to BC patients. Although significant achievements have been made through treatment with ICIs, some people who experience serious immune-related adverse events (IrAEs) are still insensitive to this approach. The response to ICI tre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: befff90e-c2b5-54e2-86cb-3f6d4f4608d0
DOI: 10.21203/rs.3.rs-1078018/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Analysis of the Immune Microenvironment Reveals that CD52 is a Marker for Breast Cancer Treatment with Immune Checkpoint InhibitorsDOI 10.21203/rs.3.rs-1078018/v1Read

CD52 is a prognostic biomarker and correlated with immune features in breast cancerSemantic proximity Read

CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor MicroenvironmentSemantic proximity Read

Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer.Semantic proximity Read

Landscape of Immune Cell Infiltration and Inflammatory Response-related Gene Signature in Breast Cancer: an Experimental Validation StudySemantic proximity Read

Screening of tumor microenvironment-related prognostic genes in breast cancer by data miningSemantic proximity Read

TPD52 as a Therapeutic Target Identified by Machine Learning Shapes the Immune Microenvironment in Breast CancerSemantic proximity Read

ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironmentSemantic proximity Read

Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA databaseSemantic proximity Read

Construction and Validation of Immune-Related LncRNA Signature to Predict the Prognosis and Therapeutic Efficacy of Breast CancerSemantic proximity Read

Integrated transcriptome and single-cell sequencing reveals M2-like tumor-associated macrophages-related prognostic signatures in breast cancerSemantic proximity Read